Generex taps Pfizer's Eagle for scientific advisory board
WORCESTER, Mass. Generex has appointed a Pfizer executive to help with its cancer and influenza vaccines program.
Generex announced Thursday the appointment of Craig Eagle to its scientific advisory board as it seeks to develop cancer and influenza vaccines through its subsidiary, Antigen Express, also known as Generex Oncology. Eagle is VP strategic alliances and partnerships at Pfizer’s cancer business unit.
“We are very pleased to add Dr. Eagle to our team of scientific advisers,” Generex president and CEO Anna Gluskin said. “His wealth of experience in ongology and drug development will be invaluable as we work to advance our vaccine technologies at Antigen Express.”